Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
También te puede gustar
Ganadores
Últimas noticias cripto
Las reuniones futuras de la Reserva Federal corren el riesgo de ver un aumento de los desacuerdos que alimentan la volatilidad del mercado
Tom Lee: La relación riesgo-recompensa de BTC y ETH se vuelve bastante atractiva
Coinbase ahora está en vivo con las operaciones al contado de Rayls (RLS)
Cierta dirección de ballena ha depositado 10 millones de U en HyperLiquid, iniciando una posición larga de 20x ETH.
Coinbase to List Rayls (RLS)
Atención al cliente:@weikecs
Cooperación comercial:@weikecs
Trading cuantitativo y MM:[email protected]
Servicios VIP:[email protected]